Polatuzumab [2279068-37-8]

TargetMol Chemicals

Polatuzumab [2279068-37-8]

9

2279068-37-8

Research Use Only

Polatuzumab

SDS-PAGE:96.4%;SEC-HPLC:99.7%

Approximately 145.24 kDa

Polatuzumab is a monoclonal antibody that targets CD79b and carries chemotherapeutically active molecules.Polatuzumab adheres to CD79b proteins and transports the chemotherapeutically active molecules into cells to kill them.Polatuzumab can be used to synthesize the antibody-compound coupling, Polatuzumab Vedotin.

3 years

-20°C

12352203